◀ Back to FOS
FOS — PRL
Text-mined interactions from Literome
Olazabal et al., Mol Endocrinol 2000
:
Using PRLR mutants and the PRLR short form, we have found that both homodimerization of PRLR wild type and the integrity of box-1 and C-distal tyrosine of PRLR intracellular domain are needed in
PRL induced proliferation and
AP-1 activation ... We found that Dex negatively regulates
PRL induced proliferation and
AP-1 site activation
Cave et al., Neuroendocrinology 2001
:
Within the TH-ir neurones,
PRL induced a significant increase in
c-Fos in the dorsomedial portion of the mid-arcuate nucleus ( p < 0.05 ) ...
PRL also
induced c-Fos expression in the supraoptic nucleus (SON) ( 11.7 +/- 3.2 vs. 3.0 +/- 1.4 cells/section for PRL and control rats, respectively ; p < 0.05 ), but not in the medial preoptic nucleus, ventromedial nucleus or the dorsomedial nucleus, areas reported to either contain gonadotropin releasing hormone neurones or express PRL receptors
Domínguez-Cáceres et al., Oncogene 2004
:
Since IEG are essential for cell cycle progression, we have studied how
PRL controls expression of c-Myc mRNA and
c-Fos
Gutzman et al., Mol Endocrinol 2005
(Breast Neoplasms...) :
Here we demonstrate that
PRL and E2 cooperatively
enhance the activity of
AP-1 in MCF-7 derived cells
Romero-Prado et al., J Cell Biochem 2006
:
In the absence of FBS and in the
presence of insulin or
prolactin , cells show cytoskeletal organization and an
AP-1 transcription site activity resembling proliferative osteochondrocytes while cells in the presence of dexamethasone and added prolactin or TGF-beta resembled differentiated osteoblasts
Andria et al., Biochem Biophys Res Commun 2007
:
Prolactin expression is
induced in Jurkat T-cells by beta-catenin LEF-1,
AP-1 and cAMP
Gutzman et al., Oncogene 2007
(Neoplasms) :
Stat5 activation inhibits
prolactin induced
AP-1 activity : distinct prolactin initiated signals in tumorigenesis dependent on cell context ... Further, reduction of Stat5 protein with siRNA in T47D cells, which contain elevated Stat5, increased
PRL induced
AP-1 signals, transcripts for the AP-1 target, matrix metalloproteinase-2 and associated invasive behavior